Regeneron Pharmaceuticals
The Executive Director, Global Site Management provides enterprise-level strategic leadership and organizational accountability for global site-facing capabilities, setting the vision and operating strategy for site management across the clinical development portfolio. This role partners with internal leadership and external vendors to optimize portfolio performance, ensuring consistent quality, speed, and scalability. The position advises senior management and represents the function in key governance forums to advance the clinical trial portfolio.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
126% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Executive Director, Global Site & Study Operations, Americas
lifelancer
Head of Global Site Management
Kardigan
Manager Site Engagement
ICON plc
Associate Director, Team Lead Site Operations
Immatics
Global PV Partnership & Operations Director
Sobi
Associate Director, Site Alliances and Strategy
Summit Therapeutics,